Why did AYUR.CN stock rise 100% on 06 Mar 2026?

The 100.00% rise to C$0.01 occurred on thin volume (12,030.00) after a recent earnings announcement. Low liquidity and small order flows can magnify price moves in micro-cap names, so the jump likely reflects concentrated trades rather than broad buying.

What are realistic price targets for AYUR.CN stock?

Meyka AI’s model sets a near-term target of C$0.02 (quarterly) and a 12-month projection of about C$0.01194. These imply +100.00% and +19.42% from C$0.01 respectively. Forecasts are model-based projections and not guarantees.

How does AYUR.CN stock compare to the Healthcare sector?

AYUR.CN trades with negative EPS and a low price-to-sales ratio (~0.06). The Canadian Healthcare average PE is about 13.90, so AYUR.CN’s metrics reflect micro-cap risk and weak profitability versus sector peers.

What are the main risks for AYUR.CN stock traders?

Main risks include very low liquidity, negative earnings, a current ratio around 0.61, and potential volatility from concentrated orders. Use tight position sizing and limit orders when trading this micro-cap on CNQ in CAD.

CA Stocks

AYUR.CN Ayurcann Holdings Corp. (CNQ) up 100% to C$0.01 on 06 Mar 2026: watch liquidity and forecast

ByHuzaifa Zahoor March 6, 2026March 6, 2026

AYUR.CN stock jumped 100.00% to C$0.01 during market hours on 06 Mar 2026 on the CNQ (Canada) as intraday trades pushed the price from the previous close of C$0.005. Volume remained modest at 12,030.00 shares versus a 50-day average near 152,341.00, so liquidity is a key watch. The move follows a recent earnings announcement and places Ayurcann Holdings Corp. under scrutiny for valuation, near-term catalysts and the reliability of short bursts in thinly traded small-cap healthcare names.